Announcement

Exercise Period XPG-W4 (March 2024)

11/03/2024

Notification the final exercise and request for suspension of XPG-W4 (Revised)

23/02/2024

Management Discussion and Analysis Yearly Ending 31 Dec 2023

23/02/2024

Financial Performance Yearly (F45) (Audited)

23/02/2024

Notification of the resolutions of the Board of Directors' Meeting No. 2/2024, changes in directors' position, omission of dividend payment, and set date for AGM 2024

23/02/2024

Trading Suspension and termination of listing status of XPG-W4

20/02/2024

Notification the final exercise and request for suspension of XPG-W4

16/02/2024

Notification of the appointment of Chief Executive Officer

09/02/2024

Report on the results of the Exercise of XPG-W4 (F53-5)

02/01/2024

List of securities which has triggered the Market Surveillance Measures

21/12/2023

Clarification of Trading Alert List

21/12/2023

Trading Alert List Information

21/12/2023

Notification the exercise of XPG-W4

12/12/2023

Notification of shareholders' rights to propose the agenda for AGM in advance

14/11/2023

Financial Performance Quarter 3 (F45) (Reviewed) (Revised)

13/11/2023

Financial Statement Quarter 3/2023 (Reviewed)

10/11/2023

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023

10/11/2023

Financial Performance Quarter 3 (F45) (Reviewed)

10/11/2023

Notification of amendments to the charter of the Audit Committee and F. 24-1

10/11/2023

Report on the results of sale of securities (F53-5)

05/10/2023